Gyre Therapeutics Inc (GYRE)

R&D Expenses

$33.05M

TTM · Period ending: · USD

GYRE logo

GYRE R&D Expenses

Latest reported$33.05M
GYRE TTM R&D Expenses ($24.25M → $33.05M)
High-resolution chart · PNG

GYRE r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gyre Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
33,052,000
22,267,000
18,624,000
17,521,000
17,933,000
12,937,000
12,024,000
12,880,000
13,114,000
13,327,000
13,780,000
15,430,152
18,704,146
16,940,146
23,895,146
33,811,994
47,796,000
61,336,000
68,759,000
67,135,000
59,117,000
56,679,000
52,930,000
49,212,000
46,890,000
45,095,000
43,858,000
41,304,000
36,952,000
29,730,000
21,474,000
16,796,000
15,026,000
14,538,000
12,828,000
12,379,000
11,970,000
11,321,000
11,546,000
10,200,000
8,290,000
5,904,000
5,682,000
-7,960,000
-21,023,000
-30,213,000
-23,197,000
-567,000
21,322,000
39,600,000
38,840,000
40,426,000
36,548,000
39,606,000
49,087,000
62,816,000
81,826,000
89,499,000
95,215,000
91,634,000
83,519,000
77,456,000
64,546,000
52,068,000
44,364,000
41,291,000
40,179,000
40,833,753
41,925,782
41,394,418
40,981,000
40,229,546
38,949,047
37,510,739
34,619,494
31,840,571
27,701,100
23,217,406
21,787,873
20,297,130
21,226,372
23,918,488
24,250,760
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.